TEM:NSD-Tempus AI, Inc. Class A Common Stock (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 61.37

Change

0.00 (0.00)%

Market Cap

USD 9.87B

Volume

0.02B

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-10 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

N/A

USD 28.76B
HQY HealthEquity Inc

N/A

USD 7.83B
WAY Waystar Holding Corp. Common S..

N/A

USD 6.42B
BTSG BrightSpring Health Services, ..

N/A

USD 3.00B
PRVA Privia Health Group Inc

N/A

USD 2.92B
CERT Certara Inc

N/A

USD 1.94B
PINC Premier Inc

N/A

USD 1.93B
SDGR Schrodinger Inc

N/A

USD 1.79B
GDRX Goodrx Holdings Inc

N/A

USD 1.55B
OMCL Omnicell Inc

N/A

USD 1.21B

ETFs Containing TEM

ARCG:LSE ARK Genomic Revolution UC.. 9.09 % 0.00 %

N/A

USD 8.76M
ARKG:LSE ARK Genomic Revolution UC.. 8.27 % 0.00 %

N/A

USD 8.76M
REMX VanEck Rare Earth/Strateg.. 6.39 % 0.59 %

N/A

N/A
PSCM Invesco S&P SmallCap Mate.. 4.95 % 0.29 %

N/A

USD 0.01B
ARCK:LSE ARK Innovation UCITS ETF .. 4.69 % 0.00 %

N/A

USD 0.04B
ARKK:LSE ARK Innovation UCITS ETF .. 4.16 % 0.00 %

N/A

USD 0.04B
THNQ Robo Global® Artificial .. 2.80 % 0.00 %

N/A

USD 0.17B
AIAG:LSE L&G Artificial Intelligen.. 2.34 % 0.00 %

N/A

USD 0.77B
AIAI:LSE L&G Artificial Intelligen.. 2.34 % 0.00 %

N/A

USD 0.77B
SPXZ 1.50 % 0.00 %

N/A

N/A
ARKG ARK Genomic Revolution ET.. 0.00 % 0.75 %

N/A

USD 0.94B
ARKK ARK Innovation ETF 0.00 % 0.75 %

N/A

USD 4.88B
PBW Invesco WilderHill Clean .. 0.00 % 0.70 %

N/A

N/A
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

N/A

USD 0.04B
XME SPDR® S&P Metals and Min.. 0.00 % 0.35 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 81.78% 98% N/A 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.78% 98% N/A 96% N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 9.87B 98% N/A 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector